Pittenger & Anderson Inc’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-939
| Closed | -$437K | – | 467 |
|
|
2024
Q3 | $437K | Buy |
939
+720
| +329% | +$335K | 0.02% | 189 |
|
|
2024
Q2 | $103K | Buy |
+219
| New | +$103K | ﹤0.01% | 267 |
|
|
2023
Q1 | – | Sell |
-325
| Closed | -$93.9K | – | 457 |
|
|
2022
Q4 | $93.9K | Buy |
+325
| New | +$93.9K | 0.01% | 244 |
|
|
2021
Q2 | – | Sell |
-93
| Closed | -$20K | – | 424 |
|
|
2021
Q1 | $20K | Sell |
93
-530
| -85% | -$114K | ﹤0.01% | 291 |
|
|
2020
Q4 | $147K | Buy |
623
+360
| +137% | +$84.9K | 0.01% | 210 |
|
|
2020
Q3 | $72K | Buy |
263
+27
| +11% | +$7.39K | ﹤0.01% | 235 |
|
|
2020
Q2 | $69K | Hold |
236
| – | – | ﹤0.01% | 229 |
|
|
2020
Q1 | $56K | Buy |
236
+20
| +9% | +$4.75K | ﹤0.01% | 232 |
|
|
2019
Q4 | $47K | Buy |
216
+25
| +13% | +$5.44K | ﹤0.01% | 275 |
|
|
2019
Q3 | $32K | Hold |
191
| – | – | ﹤0.01% | 283 |
|
|
2019
Q2 | $35K | Hold |
191
| – | – | ﹤0.01% | 277 |
|
|
2019
Q1 | $35K | Buy |
191
+75
| +65% | +$13.7K | ﹤0.01% | 284 |
|
|
2018
Q4 | $19K | Buy |
116
+4
| +4% | +$655 | ﹤0.01% | 288 |
|
|
2018
Q3 | $22K | Buy |
112
+7
| +7% | +$1.38K | ﹤0.01% | 297 |
|
|
2018
Q2 | $18K | Hold |
105
| – | – | ﹤0.01% | 306 |
|
|
2018
Q1 | $17K | Buy |
+105
| New | +$17K | ﹤0.01% | 308 |
|
|
2016
Q1 | – | Sell |
-50
| Closed | -$6K | – | 418 |
|
|
2015
Q4 | $6K | Hold |
50
| – | – | ﹤0.01% | 380 |
|
|
2015
Q3 | $5K | Hold |
50
| – | – | ﹤0.01% | 414 |
|
|
2015
Q2 | $6K | Buy |
50
+25
| +100% | +$3K | ﹤0.01% | 395 |
|
|
2015
Q1 | $3K | Hold |
25
| – | – | ﹤0.01% | 406 |
|
|
2014
Q4 | $3K | Buy |
+25
| New | +$3K | ﹤0.01% | 406 |
|